Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Overview
Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Companies Involved in Therapeutics Development
AbbVie Inc
Amgen Inc
Boehringer Ingelheim Intertiol GmbH
Bristol-Myers Squibb Co
Constellation Pharmaceuticals Inc
Ningbo Wenda Pharmaceutical Technology Co Ltd
Roivant Sciences Ltd
Zenith Epigenetics Ltd
Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Drug Profiles
ABBV-744 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BI-894999 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CC-95775 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NHWD-870 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NUE-19796 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NUE-20798 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pelabresib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
QCA-570 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit BET 3 for Metastatic Castration Resistant Prostate Cancer - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZEN-3694 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Dormant Products
Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Discontinued Products
Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) - Product Development Milestones
Featured News & Press Releases
Jun 11, 2021: Constellation Pharmaceuticals provides an update from the ongoing MANIFEST study of Pelabresib
Jun 11, 2021: Constellation Pharmaceuticals provides an update from the Ongoing MANIFEST study of Pelabresib
Mar 15, 2021: Zenith Epigenetics announces dosing of first mCRPC patient with a combition of ZEN-3694 + Merck’s immune check point inhibitor KEYTRUDA
Jan 07, 2021: Constellation Pharmaceuticals appoints Brendan Delaney as Chief Commercial Officer
Dec 06, 2020: Constellation Pharmaceuticals provides update of MANIFEST study for CPI-0610 at ASH Meeting
Nov 23, 2020: Constellation Pharmaceuticals to host alyst / investor event to discuss update of MANIFEST clinical trial for CPI-0610 presented at ASH Meeting
Jul 29, 2020: Zenith Epigenetics advances ZEN-3694 in multiple cancer programs
Jul 29, 2020: Researchers optimistic after dose-determining trial of compound against metastatic castration-resistant prostate cancer
Jun 12, 2020: Constellation Pharmaceuticals provides updates of MANIFEST study for CPI-0610 and EZH2 Franchise
May 28, 2020: Constellation Pharmaceuticals to host alyst/investor event to discuss update of MANIFEST clinical trial for CPI-0610
May 28, 2020: Constellation Pharmaceuticals to host alyst / investor event to discuss update of MANIFEST clinical trial for CPI-0610
May 14, 2020: Constellation Pharmaceuticals provides update of prelimiry data for CPI-0610 in three EHA Abstracts
Apr 15, 2020: New cancer drug shrinks tumors, reduces side effects, in animal studies
Jan 07, 2020: Zenith Epigenetics receives US$5 million milestone payment from Newsoara
Dec 19, 2019: Zenith Epigenetics announces clinical advancement of ZEN-3694
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Top 10 Indications, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021

List of Tables

List of Tables
Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Indications, 2021
Number of Products under Development by Indications, 2021 (Contd..1)
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Number of Products under Investigation by Universities/Institutes, 2021
Products under Investigation by Universities/Institutes, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Pipeline by AbbVie Inc, 2021
Pipeline by Amgen Inc, 2021
Pipeline by Boehringer Ingelheim International GmbH, 2021
Pipeline by Bristol-Myers Squibb Co, 2021
Pipeline by Constellation Pharmaceuticals Inc, 2021
Pipeline by Ningbo Wenda Pharmaceutical Technology Co Ltd, 2021
Pipeline by Roivant Sciences Ltd, 2021
Pipeline by Zenith Epigenetics Ltd, 2021
Dormant Products, 2021
Dormant Products, 2021 (Contd..1)
Discontinued Products, 2021